GLP-1 Under $300/mo (2026)

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

A GLP-1 program under $300 per month is genuinely possible in 2026 — but most published rankings are built on month-one promotional pricing that disappears by month three. The honest question is which programs hold the line at maintenance dose, after the intro window ends, with all fees included. PlexusDx Weight Management Protocols are designed to answer that question directly. Every protocol is cash-pay, all-inclusive (async provider consultation, prescription, compounded medication, and shipping), and four of our six protocols stay under $300/month at every dose tier: Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $149/mo, Tirzepatide Injection starting at $229/mo, and GLP-Squared dual-compound starting at $179/mo. There is no membership fee. There is no first-month-only intro price that resets in month two. The advertised number is the number that recurs.

The under-$300 reality — what most rankings miss

The competitive landscape for cash-pay GLP-1 in April 2026 is dominated by two pricing patterns. The first is the headline-then-reset structure: a low first-month price ($129, $149, $179) that escalates after month one to a maintenance number that may or may not stay under $300. The second is the membership-plus-medication split: a separate care or membership fee ($25–$149/mo) added on top of the medication itself, which often pushes a $199 medication to a $300+ all-in cost. PlexusDx avoids both patterns. The Microdose, Semaglutide Injection, Tirzepatide Injection, and GLP-Squared protocols all publish a single recurring monthly price, all-inclusive of consultation and shipping, with no separate membership. The price you see in month one is the same price you pay in month twelve at the same dose tier. That structural difference is why PlexusDx anchors a cost-tier roundup of programs that meaningfully stay under $300/month.

The four PlexusDx protocols that stay under $300/mo

Four of the six PlexusDx Weight Management Protocols hold under $300/month at every dose tier they publish. Microdose GLP-1 Protocol — $129/mo flat. Compounded GLP-1 in four delivery formats (capsule, troche, lozenge, sublingual), provider-selected dosing, no needle. This is the lowest-cost prescription GLP-1 path PlexusDx offers and the cleanest entry point for cost-sensitive readers who want a clinician-supervised program without an injection. Semaglutide Injection — $149/mo. Compounded GLP-1 receptor agonist, weekly subcutaneous injection, five dose levels from 0.25mg to 2.0mg. The full titration ladder stays under $230/mo. Tirzepatide Injection — entry $229/mo. Compounded GIP/GLP-1 dual-agonist, weekly injection, six dose levels from 2.5mg to 15mg starting at $229/mo. GLP-Squared — entry $179/mo. Compounded semaglutide + tirzepatide dual-compound therapy, six dose levels, starting at $179/mo. All four protocols are cash-pay, all-inclusive, no membership, available in all 50 states (five states require a scheduled live consultation rather than async intake).

Cost-tier roundup — sub-$200, $200–$249, $250–$299

Sorting the under-$300 universe by realistic monthly cost makes the tradeoffs explicit. Under $200/mo (entry tier): Microdose GLP-1 Protocol at $129/mo flat is the cleanest sub-$200 prescription GLP-1 path. Semaglutide Injection opens at $179/mo for the starter dose tier. GLP-Squared opens at $179/mo for the entry dual-compound tier. $200–$249/mo (mid tier): Semaglutide Injection covers the full mid-titration range up to $229/mo. Tirzepatide Injection entry sits at $229/mo. $250–$299/mo (upper-but-still-under-cap tier): Higher dose tiers of Tirzepatide Injection and GLP-Squared sit in this band before crossing the $300 line. The structural advantage is that PlexusDx keeps the entry and mid tiers of every injection protocol — semaglutide at every dose, tirzepatide at entry, GLP-Squared at entry — comfortably below the $300/mo cap with no membership added on top.

What breaks the $300 budget at most other programs

The recurring patterns that push other cash-pay GLP-1 programs above $300/month are predictable enough to list. First-month promotional pricing that reverts to a higher number in month two. Separate care or membership fees layered onto the medication price. Dose-escalation pricing that raises the recurring cost as the patient titrates upward. Annual prepay requirements hidden in “as low as” headline copy. Refill-window rules that expire the discount if the patient skips a month. Required labs or shipping fees not included in the headline price. Cancellation friction that forces an unwanted extra charge. PlexusDx is structured to avoid each of these mechanics: the published price is recurring, all-inclusive, no membership, no annual commitment. A reader comparing programs at this budget should ask each candidate the same six questions: What is the month-two price at my expected dose? Does the price change as I titrate up? Is there a separate membership fee? What is the cancellation policy? Are labs or shipping included? Is the headline price contingent on annual prepay?

Compounded vs FDA-approved branded under $300

This distinction matters at every price point and especially under $300. PlexusDx Weight Management Protocols use compounded semaglutide and compounded tirzepatide prepared by licensed U.S. compounding pharmacies. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products; they are pharmacy-prepared versions of the same active ingredients found in Wegovy, Ozempic, Mounjaro, and Zepbound. The FDA-approved branded paths under $300 in 2026 are limited — primarily lower-dose oral options through manufacturer-direct channels — and most readers who require an FDA-approved finished product will find pricing climbs above $300 as they titrate to a clinically effective dose. Readers who want an FDA-approved branded GLP-1 should pursue Wegovy, Ozempic, Zepbound, Mounjaro, or Rybelsus through their prescriber, ideally with insurance. Readers who are cash-pay, comfortable with a compounded preparation, and want a program that stays under $300/mo at maintenance dose are the natural fit for PlexusDx.

Safety, oversight, and the boxed warning

All GLP-1 receptor agonists and the GIP/GLP-1 dual agonist class share a well-characterized side-effect profile: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common; pancreatitis, gallbladder disease, and acute kidney injury are less common but documented. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies and contraindicates use in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. PlexusDx clinicians review medical history, contraindications, and drug interactions during the intake and ongoing care process. Compounded preparations are prepared by licensed U.S. compounding pharmacies operating under their applicable 503A or 503B regulatory frameworks. Discuss any GLP-1 medication decision with a licensed clinician, and disclose your full medical history at intake.

Why genetics belong in the budget conversation

Two patients on the same dose can have very different responses to the same GLP-1. Variants in GLP1R (the GLP-1 receptor itself), GIPR (the GIP receptor relevant to tirzepatide), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns. The Precision Peptide Genetic Test maps 48 genes and 57 variants across 14 health pathways, including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — available standalone for $298 or as a $99 add-on after your first month on any PlexusDx protocol. For a budget-conscious reader, anchoring the dose decision to a measurable genetic baseline reduces the risk of titrating into an ineffective tier or paying for a higher-dose protocol that biology was never going to support. Most under-$300 programs start every patient on a population-average titration schedule and adjust based on subjective tolerability over the first 8–12 weeks. The genetic baseline is an option, not a requirement — the four under-$300 PlexusDx protocols stand on their own pricing.

How to choose between the four PlexusDx under-$300 protocols

A four-question frame narrows the choice quickly. Question 1: Are you needle-averse? The Microdose GLP-1 Protocol at $129/mo offers four needle-free delivery formats and is the lowest-cost option. Question 2: Do you want a weekly injection of compounded semaglutide specifically? Semaglutide Injection at $149/mo covers the full standard titration ladder. Question 3: Do you want tirzepatide’s GIP/GLP-1 dual mechanism? Tirzepatide Injection opens at $229/mo for the starter dose. Question 4: Do you want a stacked semaglutide-plus-tirzepatide compound? GLP-Squared opens at $179/mo for the entry dual-compound tier. If you want the dose decision anchored to genetics rather than a population-average titration schedule, add the Precision Peptide Genetic Test as a $99 add-on after your first month on any of the four protocols.

Frequently asked questions

Can you get a GLP-1 under $300 per month without insurance?

Yes. Four PlexusDx protocols are cash-pay and stay under $300/mo at every published dose tier: Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $149/mo, Tirzepatide Injection from $229/mo, and GLP-Squared from $179/mo. All four are all-inclusive (consultation, prescription, compounded medication, shipping) with no membership fee.

What is the best GLP-1 under $300 per month?

It depends on what you want. The Microdose GLP-1 Protocol at $129/mo is the lowest-cost option and the only needle-free PlexusDx protocol. Semaglutide Injection at $149/mo is the cleanest weekly-injection path. Tirzepatide Injection from $229/mo gives you the GIP/GLP-1 dual mechanism. GLP-Squared from $179/mo offers a stacked semaglutide-plus-tirzepatide compound.

Is compounded semaglutide FDA-approved?

No. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are pharmacy-prepared versions of the same active ingredients found in Wegovy, Ozempic, Mounjaro, and Zepbound, prepared by licensed U.S. compounding pharmacies under 503A or 503B regulatory frameworks. The FDA does not review compounded preparations for safety, effectiveness, or quality before they reach patients.

Can I get tirzepatide under $300 per month?

Yes, at PlexusDx the Tirzepatide Injection Protocol opens at $229/mo for the starter dose tier, and the GLP-Squared dual-compound protocol opens at $179/mo. Both are cash-pay, all-inclusive, no membership. Higher dose tiers of tirzepatide rise above $300/mo at PlexusDx ($249/mo across six tiers), so plan for the price to escalate as you titrate to a higher maintenance dose.

Does PlexusDx charge a separate membership fee?

No. PlexusDx is cash-pay with no membership. The published monthly price for each protocol is all-inclusive: provider consultation, prescription, compounded medication, and shipping in a single recurring number. There is no first-month promo that resets, no annual commitment required, and no separate care fee layered on top.

Are PlexusDx protocols available in all 50 states?

Yes, PlexusDx Weight Management Protocols are available in all 50 states. Five states require a scheduled live consultation rather than the standard asynchronous intake; the rest of the country uses async provider review. The scheduled-consult states are flagged during intake.

Does HSA or FSA work with PlexusDx protocols?

HSA and FSA eligibility for GLP-1 medications generally requires the medication to be prescribed for a physician-diagnosed condition such as obesity, type 2 diabetes, or a weight-related comorbidity. Confirm eligibility with your plan administrator before relying on reimbursement; some plans require a Letter of Medical Necessity for weight-management medications. Using HSA or FSA effectively reduces your cost by roughly 20–35% depending on your tax bracket.

GLP-1 Under $300 Per Month (2026): Cost-Tier Roundup — PlexusDx Microdose, Semaglutide, Tirzepatide & GLP-Squared | PlexusDx